Abstract
reported in 2009 [1, 2] . According to this report, 183 million people with DM are undiagnosed [1] .
Taking into consideration these facts, as well as knowing that a good metabolic control and the importance of lifestyle components in preventing the development and the progression of DM chronic complications [3] , we intended to evaluate these elements in a large number of people, both previously diagnosed with DM, as well as people from the general population.
Our purposes were to identify the sociodemographical characteristics of the subjects diagnosed with DM prior to this study, to establish the percent they represent of the studied group, as well as to evaluate the metabolic control of the subjects enrolled in the study. Another aim of this study was to ascertain whether the blood glucose level or the HbA1c measurement leads to the detection of a higher percentage of DM newly diagnosed cases.
Material and Method
The study was conducted in 3 Romanian cities and it enrolled 4133 subjects (58% females and 42% males), 1340 from Craiova, 1224 from Oradea and 1569 from Sibiu, which gave their written informed consent for participating in this research. All the participants filled in a questionnaire regarding their age, sex, if they were previously diagnosed with DM, and if so, the duration of DM and the current treatment. We measured the subjects' weight and height, which were needed for calculating the Body Mass Index (BMI). Blood glucose level and HbA1c level were also determined.
The blood glucose level was determined using capillary blood, which implied using an international formula in order to asses the plasma glucose level. The HbA1c level was determined, using a standardized method, in all the subjects that declared having been diagnosed with DM prior to our study and in 604 subjects from the general population. All the recordings and determinations were performed by specialized medical staff. These data were stastically analyzed by ISRA Center using SPSL software.
Results
1413 subjects (34%) declared having been diagnosed with DM previously to this study. All the parameters previously discussed were analyzed in these subjects.
The BMI distribution of the subjects diagnosed with DM prior to this study, showed that only 14% of them had a normal range BMI, while 40%, respectively 45% were overweight, respectively obese ( Figure 1 ). These subjects' age distribution was also analyzed. It was ascertained that 91% of the subjects were aged over 50 years old, the highest number of subjects (33%) being aged between 61 and 70 years old (Figure 2 ). All the subjects previously diagnosed with DM were asked to declare the duration of DM in years. It was proven that more than half of them (56%) have been diagnosed within the last 5 years. For less than a quarter of them (22%), the diagnosis was established from 6 to 10 years ago, as shown in Figure 3 .
Our next step was to identify the relationship between the subjects' age and the duration of DM. Figure 4 reveals that a higher percentage of subjects under 61 have been diagnosed during the last 5 years, while 52% of the subjects over 70 years old were diagnosed more than 6 years ago.
The subjects that reported having been diagnosed with DM prior to this research were also questioned about their current treatment. Most of them, 65%, take OAA, 13% take insulin and 4% take both OAA and insulin. 18% of the subjects acknowledged they do not follow a treatment ( Figure 5 ). There are no significant differences regarding the gender distribution. When analyzing the current treatment within age groups, we found that younger people (the under 50 years age group) take OAA and insulin in the same proportion (39%), significantly lower, respectively higher when compared to the original percentages (p < 0,05) ( Figure 6 ).
Both OAA and insulin have therapeutic effects and/or side effects upon the subjects' weight, and the patient's BMI is important in choosing the optimal treatment. Therefore, we intended to reveal the possible therapeutic schemes variations within subjects' BMI classes (Figure 7 ). Significantly differences existed within the subjects with normal range BMI, only 53% of whom take OAA (p < 0.05). 19% take insulin (p < 0.05) and 2 % take both OAA and insulin. Surprisingly, 25% of them do not follow any treatment. In regard to the overweight subjects, only 2% of them take both insulin and OAA. The association OAA-insulin also differed in subjects with class III obesity. This treatment scheme was reported by 14%, a significantly higher percent (p < 0.05). Because the number of subjects with underweight was very low (only 8), the findings regarding these subjects can not be taken into consideration. Blood glucose level and HbA1c were determined in all the subjects with DM enrolled in the study. HbA1c is a very important parameter which must be evaluated when discussing the metabolic control in subjects with DM. The evaluation of HbA1c in the studied subjects showed that only 36% of them had a good metabolic control, their HbA1c being <6.5%, as shown in Figure 8 . When analyzing these numbers, we must not forget that the subjects' comorbidities and the existence of DM chronic complications were not assessed and we did not know the HbA1c individual targets. 66% of the studied subjects did not report being diagnosed with DM previously to this study. We proceeded to analyze the recorded parameters with the following findings.
Regarding the BMI distribution, 29% of these subjects had a normal range BMI, 40% were overweight and 30% were obese as presented in Figure 9 .
The subjects were also divided into 4 age groups. Comparing the age distribution, we noticed that the subjects aged 50 to 60 years old were the most interested in having their blood glucose and HbA1c tested. Only 20% of the subjects who did not declare DM were aged over 70 (Figure 10 ). One of the most interesting parts of this study was represented by the blood glucose and HbA1c values analysis in the subjects who did not declare being diagnosed with DM prior to this study. Figure 11 shows the analysis performed regarding the determined blood glucose levels. In order to correctly evaluate this parameter, the subjects were asked to state if the value determined was fasting blood glucose or not. 60% of the subjects who were not diagnosed with DM prior to this study had a fasting blood glucose level within normal range. However, in 20% of them we found a blood glucose level ≥126mg/dL, leading to a high number of newly diagnosed DM cases. These subjects were referred to Diabetes Nutrition and metabolic Diseases out-patient compartments for further investigations. Taking into discussion the random blood glucose values, only 2% of the subjects had a random blood glucose ≥200mg/dL, which imposed further investigations in our outpatient departments. The last parameter evaluated was the HbA1c value. This was not determined for all the subjects. We performed this measurement only in 604 subjects who were no diagnosed with DM prior to the study. The analysis regarding the HbA1c distribution is shown in Figure 12 : 49% of the subjects had HbA1c values which suggest prediabetes and 17% of these subjects had a values ≥ 6.5%, filling one of the DM diagnosis criteria. Only 33% of the subjects who did not declare DM and had their HbA1c determined presented normal range HbA1c. The subjects whose HbA1c values were abnormal were referred to Diabetes Nutrition and Metabolic Diseases ambulatories for further investigations. 265 subjects from Craiova, who did not report having been diagnosed with DM previously to this study, had their HbA1c level determined. 45% had a value within the normal range, in 47% of the cases the HbA1c was suggestive for prediabetes and 8% had HbA1c values ≥6.5%, a value which indicated DM. Table 1 and Table 2 show the relationships between HbA1c values and the blood glucose level in these subjects. This analysis shows that only 21.7% of the subjects who presented fasting blood glucose levels suggesting DM had an HbA1c≥6.5%, 52.2% had an HbA1c value suggesting prediabetes and 26% of these subjects had normal range HbA1c. When analyzing the subjects with HbA1c≥6.5%, only 14.3% of them had normal blood glucose levels. Therefore, the simultaneous determination of these parameters leads to the detection of a higher number of newly diagnosed DM. Discussions DM prevalence in Romania in 2010 was estimated at 8.4% [2] . About a third of the subjects enrolled in this study have been previously diagnosed with DM. Most of them, reported the diagnosis during the last 10 years, 5 out of 10 subjects having been diagnosed within the last 5 years.
In our study, 59% of the subjects with DM were aged over 61, although according to IDF the greatest number of people with DM are aged 40 to 59 years [1] .
Our study came to emphasise the strong relationship between overweight and obesity and the development of DM. It is known that a BMI ranging between 27.2 -29.4Kg/m 2 leads to a 100 fold increase in risk of developing type 2 DM, while a BMI ≥29.4Kg/m 2 leads to a 300 fold risk increase [4] .
Among the subjects that have not been diagnosed with DM, there were ones with abnormal blood glucose levels and/or HbA1c values. Having a single measurement we can not confirm the existence of prediabetes or DM, which requires 2 measurements. Furthermore, when discussing the blood glucose level, we must remember that the determinations were made from capillary blood and not plasma. Additionally, in some of the subjects only an oral glucose tolerance test might confirm the diagnosis. 17% of all the subjects who were not previously diagnosed with DM had HbA1c values ≥6.5%. When discussing the fasting blood glucose levels, 20% of the subjects who did not report DM had values ≥126mg/dL. These high percentages may be explained by the fact that many people having specific symptoms might have been interested in participating in our study.
